South Africa halts AstraZeneca jab over new strain

South Africa halts AstraZeneca jab over new strain
  • Clock-gray 08:19
  • calendar-gray 08 February 2021

South Africa has put its roll-out of the Oxford-AstraZeneca vaccine on hold after a study showed "disappointing" results against its new Covid variant, APA reports citing BBC.

Scientists say the strain accounts for 90% of new Covid cases in South Africa.

The study, involving around 2,000 people, found the vaccine offered "minimal protection" against mild and moderate cases of Covid-19.

South Africa has received 1m doses of the AstraZeneca jab and was due to start vaccinating people next week.

apa-logo-mini

Other news